FDA Inspection
Fresenius Kabi Oncology LimitedFresenius Kabi Oncology Limited – FDA Inspection, Jan 18, 2013
Record Details
This FDA Inspection record concerns Fresenius Kabi Oncology Limited, with an inspection on January 18, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 18, 2013
- Product Type
- Drugs
View Company Profile
ID · 283b6f0d-f1b9-4603-a26a-cfee0923ba0c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 815170
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fresenius Kabi Oncology Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 3, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Oncology Limited
- FDA Inspection 1013712 - 2017-05-24
- FDA Inspection 924144 - 2015-03-03
- FDA Inspection 630128 - 2009-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.